期刊文献+

Toll样受体4在胃食管交界部腺癌发展中的作用及与血管密度的关系 被引量:1

Relationship between TLR4 expression and angiogenesis in human AEJ
下载PDF
导出
摘要 目的 :探讨Toll样受体4(TLR4)在胃食管交界部腺癌发展中的作用及其与血管生成之间的关系。方法 :采用回顾分析,通过免疫组化法检测43例(其中23例为随访证实已出现复发转移)经病理证实的胃食管交界部腺癌手术切除标本中TLR4蛋白的表达;采用CD34抗体标记微血管内皮细胞,计算微血管密度(MVD)。分析TLR4蛋白的表达、MVD与胃食管交界部腺癌主要临床病理参数以及预后的关系。结果:TLR4蛋白的阳性表达率为69.8%,其中A组(复发转移组)TLR4蛋白阳性率为82.6%,明显高于对照组B组(55.0%,P<0.05);有淋巴结转移者的TLR4蛋白阳性表达率(79.3%)高于无淋巴结转移者(50.0%,P=0.05);TNM分期为Ⅲ+Ⅳ期者的TLR4蛋白阳性表达率(82.8%),明显高于Ⅰ+Ⅱ期者(42.9%,P<0.01)。TLR4蛋白的表达与MVD呈正相关(P=0.008)。结论:TLR4的高表达与胃食管交界部腺癌的发生发展及患者的预后情况密切相关,可能与TLR4促进肿瘤微血管生成相关。 Objective:To investigate the effects of Toll-like receptor 4 overexpression in human AEJ and the relationship between TLR4 overexpression and angiogenesis. Methods:Through retrospective analysis, a total of 43 surgically resected human AEJ specimens were investigated for TLR4 protein expression by immunohistochemical SP methods,CD34 antibody was used to mark microvascular endothelial cells and the microvessel density(MVD) was determined The correlation among TLR4 protein expression and MVD and clinicopathologic features of AEJ was analyzed. Results:TLR4 protein positive rate was 69.8%, rate of 82.6% in group A which was metastasis and recurrence was significantly higher than that of the control group B(P 〈 0.05). TLR4 protein positive rate in the cases with lymph node metastasis(79.3%)was significantly higher than that in the cases without lymph node metastasis(50.0%) (P=0.05). TLR4 protein positive rate in the patients with stage Ⅲ and IV of TNM classification was 82.8%, which was significantly higher than that in the patients with stage I and Ⅱ (42.9%,P 〈 0.05). MVD was closely related to TNM stage of AEJ (P=0.008). There was a strong positive correlation between TLR4 protein expression and MVD(P=0.012). There was no statistical significance among tumor grade,size,vascular metastasis,and neural invasion. Conclusions:TLR4 expression was closely related to the progression of tumor and prognosis of patients and might be related to the promotion of tumor angiogenesis.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2015年第5期678-681,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金资助(81270298)
关键词 胃食管交界部腺癌 TOLL样受体 微血管密度 AEJ Toll-like receptor MVD
  • 相关文献

参考文献12

二级参考文献58

  • 1Burkhard HA von Rahden,Hubert J Stein,J Rüdiger Siewert.Surgical management of esophagogastric junction tumors[J].World Journal of Gastroenterology,2006,12(41):6608-6613. 被引量:18
  • 2Husemann B.Cardia carcinoma considered as a distinct clinical entity.Br J Surg,1989,76(2):136-139.
  • 3Siewert JR,Holscher AH,Becker K,et al.Cardia cancer:attempt at a therapeuticaiiy relevant classification.Chirurg,1987,58(1):25-32.
  • 4Siewert JR,Stein HJ.Classification of the adenocarcinoma of the esophagogastric junction.Br J Surg,1998,85(11):1457-1459.
  • 5Siewert JR,Feith M,Stein HJ.Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction:relevance of a topographic-anatomic subclassification.J Surg Oncol,2005,90(3):139-146.
  • 6Barboer AP,Rizk NP,Gonen M,et al.Adenocarcinoma of the gastroesophageal junction influence of esophageal resection margin and operative approach on outcome.Ann Surg,2007,246(1):1-8.
  • 7Feith M,Stein HJ,Siewert JR,et al.Adenocarcinoma of the esophagogastric junction:surgical therapy based on 1602 consecutive resected patients.Surg Oncol Clin N Am,2006,15(4):751-764.
  • 8Hulscher JB,Tijssen JG,Obertop H,et al.Transthoracic versus transhiatal resection for carcinoma of the esophagus:a meta-analysis.Ann Thorac Surg,2001,72(1):306-313.
  • 9Stein HJ,Feith M,Siewert JR.Cancer of the esophagogastric junction.Surg Oncol,2000,9(1):35-41.
  • 10Hulscher JB,van Sandick JW,de Boer AG,et al.Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus.N Engl J Med,2002,347(21):1662-1669.

共引文献64

同被引文献22

  • 1Takeda K, Kaisho T, Akira S. Toll-like receptors[J]. Annu Rev Immunol, 2003,21 : 335-376. DOI : 10. 1146/annurev. immunol. 21. 120601. 141126.
  • 2Lee CC, Anvalos AM, Ploegh HL. Accessory molecules for Toll- Like receptors and their functio [ J]. Nat Rev Immunol,2012,12' (3) :168-179. DOI: 10. 1038/nri3151.
  • 3Brown J, Wang H, I-Iajishengallis GN, et al. TLR-signaling net- works: an integration of adaptor molecules, kinase, and cross-talk [J]. J Dent Res, 2011,90 (4): 417-427. DOI: 10. 1177/ 0022034510381264.
  • 4Basith S, Manavalan B, Yoo TH, et al. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense[J]. Arch Pharm Res, 2012,35 (8) : 1297-1316. DOI: 10. 1007/s12272- 012-0802-7.
  • 5Renga B, Mencarelli A, Cipriani S, et al. The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intes- tinal inflammation[J]. PLoS One,2013,8( 1 ) :e54472. DOI: 10. 1371/journal. pone. 0054472.
  • 6Rakoff-Nahoum S, Medzhitov R. Toll-like receptors and cancer [J]. Nat Rev Cancer, 2009, 9 ( 1 ) : 57-63. DOI: 10. 1038/ nrc2541.
  • 7Zhang M, Shan H, Chang P,et al. Hydrogen sulfide offers neuro- protection on traumatic brain injury in parallel with reduced apop- tosis and autophagy in mice[ J]. PLoS One,2014,9( 1 ) :e87241. DOI : 10. 1371/journal. pone. 0087241.
  • 8Ridnour LA, Chdng R, Switzer CH, et al. Molecular pathways : toll-like receptors in the tumor microenvironment-poor prognosis or new therapeutic opportunity[ J]. Clin Cancer Res, 2013,19 ( 6 ) : 1340-1346. DOI : 10.1158/1078-0432. CCR-12-0408.
  • 9Sato Y, Goto Y, Narita I-I,et al. Cancer cells expressing toll-like receptors and the tumor microcnvironment[ J]. Cancer Microenvir- on, 2009,2 ( 1 ) :205-214. DOI : 10. 1007/s12307-009-0022-y.
  • 10Zhou M, McFarland-Mancini MM, Funk HM, et al. Toll hke re- ceptor expression in normal ovary and ovarian tumors [ J ]. Cancer Immunol Immunother, 2009,58 ( 9 ) : 1375-1385. DOI : 10. 1007/s00262 -008 -0650 -y.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部